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Deoxyhypusine synthase (DHPS) utilizes the polyamine spermidine to catalyze the hypusine 
modification of the mRNA translation factor eIF5A and promotes oncogenesis through poorly-
defined mechanisms. Because germline deletion of Dhps is embryonically lethal, its role in normal 
postnatal cellular function in vivo remains unknown. We generated a mouse model that enabled 
the inducible, postnatal deletion of Dhps specifically in postnatal islet β cells, which function to 
maintain glucose homeostasis. Removal of Dhps did not have an effect under normal physiologic 
conditions. However, upon development of insulin resistance, which induces β-cell proliferation, 
Dhps deletion caused alterations in proteins required for mRNA translation and protein secretion, 
reduced production of the cell cycle molecule cyclin D2, impaired β-cell proliferation, and 
induced overt diabetes. We found that hypusine biosynthesis was downstream of protein kinase C-
ζ and was required for c-Myc-induced proliferation. Our studies reveal a requirement for DHPS in 
β cells to link polyamines to mRNA translation to effect facultative cellular proliferation and 
glucose homeostasis.
The natural polyamines (putrescine, spermidine, and spermine), which are generated 
endogenously through the action of the enzyme ornithine decarboxylase (ODC), promote 
cellular proliferation and maintenance (1). Among the polyamines, only spermidine is a 
substrate for the enzyme deoxyhypusine synthase (DHPS), which transfers a butylamine 
moiety to the ε-amine of Lys50 of eukaryotic translation initiation factor 5A (eIF5A) to form 
the rare amino acid hypusine (2). The polyamines, DHPS and eIF5A have been studied 
largely in the context of cancer, where they promote oncogenesis by enabling the production 
of proteins involved in cellular migration and growth (2–5). These factors are also important 
in normal cells during development, because germline deletion of the genes encoding 
ornithine decarboxylase (ODC; the enzyme that regulates polyamine production), DHPS and 
eIF5A in mice induce lethality during early embryonic stages (6–8). Whereas conditional 
knockouts of ODC have been described in the context of macrophage polarization (9, 10), 
the absence of animal models to study either DHPS or eIF5A in the postnatal state have 
precluded analysis of the potential role of these factors in the maintenance of normal cellular 
function.
The growth and function of islet β cells is necessary for fuel homeostasis and viability in 
mammals. β cells produce insulin, a hormone necessary for glucose disposal and the 
suppression of ketogenesis and gluconeogenesis. β cells are considered to have facultative 
proliferative activity, because they are largely replication-quiescent postnatally (11, 12), but 
can be induced to proliferate under pathophysiological conditions. For example, during 
obesity, generalized insulin resistance increases the demand for insulin secretion from β 
cells to maintain glucose homeostasis (13). In rodents, this increase in insulin secretion is 
partially met though expansion of β-cell mass (14). Although no longitudinal data are 
available in humans, cross-sectional studies similarly suggest that obese humans have 
greater β-cell mass compared to lean controls (15). Cellular replication is believed to be the 
dominant mechanism for gains in β-cell mass in mice (16), and replicating β cells has been 
detected in humans, especially in younger individuals (11, 17). The molecular mechanisms 
governing proliferation in β cells remains incompletely characterized. Given a role for 
polyamines in oncogenesis, we surmised that DHPS may be critical for the function of 
polyamines in enabling proliferation of β cells. We previously showed that the hypusine 
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modification is important in the production of stress-responsive proteins during cytokine 
signaling and endoplasmic reticulum (ER) stress in the pancreatic islet (18–20), but a role in 
facultative proliferation remained speculative.
In this study, we hypothesized that facultative gains in β-cell mass during obesity were 
mediated by the action of DHPS through its downstream hypusine modification of eIF5A. 
To test this hypothesis, we developed a mouse model to permit inducible, tissue-specific 
deletion to investigate the role of DHPS during cellular replication of β cells and glucose 
metabolism in vivo. Collectively, our studies reveal a requirement for hypusine to link 
specific mRNAs with the translational machinery to effect facultative cellular proliferation.
RESULTS
High fat diet feeding results in diabetes with attendant loss of β-cell mass in DhpsΔβ 
animals
To achieve inducible, tissue-specific deletion of Dhps in mice, we first generated mice in 
which exons 2 to 7 of the Dhps allele were flanked by Cre recombinase recognition 
sequences (loxP) (Supplemental fig. S1A). These mice were backcrossed for 10 generations 
onto the C57BL6/J background, then crossed to C57BL6/J mice harboring a transgene 
encoding the Cre recombinase-modified estrogen receptor fusion protein under control of 
the mouse Ins1 promoter (MIP1-CreERT) (21). Some of the mice were also crossed to 
Rosa26R-Tomato mice to monitor Cre-mediated recombination (22). The crosses resulted in 
the generation of multiple different mouse genotypes, which were confirmed by PCR 
genotyping (Supplemental fig. S1B). Administration of tamoxifen to DhpsloxP/loxP;MIP1-
CreERT mice at 8 weeks of age resulted in the generation of β-cell-specific knockout mice 
(henceforth referred to as DhpsΔβ mice), as shown by overlapping immunostaining of 
Tomato fluorescent protein and insulin, indicating β-cell-specific recombination at the 
Rosa26R-Tomato locus (Supplemental fig. S1C) and by immunoblotting showing reduced 
DHPS protein in pancreatic islets but not in the hypothalamus or liver (Supplemental fig. 
S1D). One week following the final tamoxifen injection, no alterations in glucose tolerance 
(by intraperitoneal glucose tolerance test, GTT) were observed in DhpsΔβ mice compared to 
littermate controls (which included both Cre-positive and loxP/loxP mice) (Supplemental 
fig. S1E and S1F), a finding suggesting that the acute loss of DHPS in β cells does not 
immediately impact glucose homeostasis.
To interrogate the role of DHPS in facultative cellular proliferation, we next subjected 
DhpsΔβ and control littermates (including Cre-positive, loxP/loxP, and wild-type controls) to 
either a high fat diet (HFD; 60% calories from fat), which induces β-cell proliferation (23), 
or to a normal chow diet (NCD, 16% calories from fat). Following 4 weeks of feeding (Fig. 
1A), both control and DhpsΔβ animals on a HFD gained equivalent weight and body fat, 
which was greater than their NCD-fed counterparts (Fig. 1B and 1C). Glucose tolerance as 
assessed by GTT did not differ between NCD-fed DhpsΔβ mice or control mice (Fig. 1D and 
1E). By contrast, HFD-fed DhpsΔβ mice exhibited frank diabetes with significantly worse 
glucose tolerance compared to HFD-fed control animals (Fig. 1F and 1G). Notably, although 
insulin sensitivity (based on insulin tolerance testing) was reduced in HFD-fed animals, 
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DhpsΔβ mice did not differ from control mice (Fig. 1H and 1I), suggesting that worsened 
glucose tolerance in DhpsΔβ mice was not due to inherent alterations in insulin sensitivity.
To evaluate β-cell function in HFD-fed DhpsΔβ mice, we performed glucose-stimulated 
insulin secretion studies in vivo. Whereas insulin levels were similar between DhpsΔβ and 
controls on a NCD, HFD-fed DhpsΔβ mice showed significantly lower absolute insulin 
levels 2 min after an intraperitoneal glucose load, and lower incremental changes in insulin 
levels compared to HFD-fed controls, consistent with an impairment in insulin secretion 
(Fig. 1J). HFD-fed DhpsΔβ mice failed to gain β-cell mass in contrast to HFD-fed controls 
(whose mass was greater than that in animals placed on a NCD) (Fig. 1K and 1L). This 
failure to gain β-cell mass was likely caused by lack of cellular accrual (proliferation) rather 
than an increase in cellular death, because we did not observe increases in TUNEL staining 
of β cells in pancreas sections from DhpsΔβ mice compared to controls (Fig. 1M and 1N).
Gene expression and proteomics analyses suggest a potential defect in mRNA translation
To interrogate the molecular effects of DHPS deficiency, we next performed RNA deep 
sequencing and global proteomics analyses on isolated islets from DhpsΔβ and control 
animals from the HFD-fed group. In RNA deep sequencing studies, islets from HFD-fed 
controls (one Cre-positive and two loxP/loxP animals) and DhpsΔβ mice showed distinct 
clustering in principal component analysis, with greater variance seen among control than 
DhpsΔβ islets (Fig. 2A). Deletion of Dhps resulted in a total of 747 genes that were 
significantly differentially expressed in islets from 4-week HFD-fed mice, when using the 
criteria of p-value<0.05 and fold-change>2.0 (Fig. 2B). By Gene Ontology Enrichment 
Analysis, the greatest enrichment of genes in DhpsΔβ islets was observed in pathways 
affecting cell cycle, mitotic nuclear division, and cell division (Fig. 2C). Virtually all of the 
genes involved in cellular replication were significantly increased in DhpsΔβ islets compared 
to control islets (Fig. 2D). Because the primary role of DHPS is the posttranslational 
activation of the mRNA translation factor eIF5A, we also performed tandem mass 
spectrometry (MS/MS)-based proteomics analysis on islets from HFD-fed mice. A total of 
130 proteins (out of a total of 1991 proteins identified) were significantly altered in DhpsΔβ 
islets compared to controls (using a p-value <0.05; Fig. 2E). Application of Gene Ontology 
Enrichment Analysis showed that these proteins clustered in pathways affecting primarily 
mRNA translation, protein folding, exocytosis, and oxidation-reduction processes (Fig. 2F)
—all pathways consistent with effects of eIF5A on translation and protein trafficking 
through the ER. Notably, because of their low abundance relative to others in the β cell, cell 
cycle proteins were either not detected or were not significantly changed in this analysis.
β-cell proliferation following HFD feeding is impaired in DhpsΔβ mice
Because DhpsΔβ mice did not accrue β-cell mass, the increases in mRNAs encoding pro-
proliferative proteins suggested to us a possible transcriptional compensatory response. β-
cell proliferation is observed as early as 1 week following initiation of HFD feeding (23–
26). We therefore examined phenotypic and molecular characteristics in control and DhpsΔβ 
mice after 1 week of NCD or HFD feeding. Immunoblots and immunostaining of islets 
revealed that the levels of hypusinated eIF5A (eIF5AHyp) increased in control animals upon 
HFD feeding (Fig. 3A and 3B and Supplemental fig. S1G), whereas in islets from DhpsΔβ 
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animals, eIF5AHyp levels by immunostaining were significantly reduced and not detectably 
changed upon HFD feeding (Fig. 3A and 3B). The intensity of immunostaining for 
eIF5ATotal did not change with diet or genotype (Fig. 3C and 3D), suggesting that the 
changes in eIF5AHyp levels are a result of posttranslational modification. Glucose tolerance, 
circulating insulin, and β-cell mass did not differ between DhpsΔβ mice and littermate 
controls on a NCD (Fig. 4A–D), whereas HFD-fed DhpsΔβ mice exhibited a small, but 
statistically insignificant, improvement in glucose tolerance compared to control mice 
following 1 week of feeding (Fig. 4E and 4F). Consistent with this finding, circulating 
insulin levels in HFD-fed DhpsΔβ mice were slightly but significantly higher than in the 
control animals (Fig. 4G). At this timepoint, β-cell mass was similar between DhpsΔβ and 
control mice fed a HFD (Fig. 4H). To interrogate alterations in β-cell proliferation, we 
performed immunofluorescence staining of pancreas sections from NCD- and HFD-fed 
animals for Ki67, a marker of cellular proliferation. One week of HFD feeding increased the 
frequency of Ki67-positive β cells compared to NCD in control littermates, an increase that 
did not occur in DhpsΔβ mice (Fig. 4I and 4J). Moreover, Ki67-positivity remained 
significantly lower in DhpsΔβ compared to control littermates when fed either a NCD or 
HFD (Fig. 4J). Together, these results suggest that loss of Dhps impairs the early β-cell 
proliferative response to a HFD.
Dhps deficiency in β cells impairs Ccnd2 mRNA translation during HFD feeding
To clarify the molecular alterations that contribute to the defective β-cell proliferative 
phenotype in DhpsΔβ mice, we evaluated in isolated islets the expression of specific genes 
involved in cell cycle progression at the G1/S boundary (Fig. 5A). The levels of several key 
mRNAs crucial to β-cell proliferation, including Ccnd2 (encoding Cyclin-D2), Ccnd1 
(encoding Cyclin-D1), and Ccna2 (encoding Cyclin-A2) did not differ between HFD-fed 
control and DhpsΔβ islets (Fig. 5B). However, Cyclin-D2 protein levels in islets were 
significantly reduced in DhpsΔβ islets compared to controls following 1 week of HFD 
feeding (Fig. 5C). By contrast, no differences were seen in the protein levels of Cyclin-D1 
(Fig. 5C).
Given the dissociation between mRNA levels and protein levels for Cyclin-D2, we next 
asked if loss of DHPS impaired the translation of Ccnd2 mRNA. We performed 
polyribosome profiling (PRP) studies using lysates from islets of 1-week HFD-fed animals. 
PRP involves sucrose gradient sedimentation of cellular extracts to fractionate total RNAs 
based on their association with ribosomes (27). RNAs associated with monoribosomes 
sediment higher in the gradient compared with those that are associated with multiple 
ribosomes (polyribosomes)—and hence are actively translated. DhpsΔβ islets were similar to 
Cre-positive control islets in terms of the polyribosome:monoribosome ratio (or P/M ratio, 
which reflects the relative association of RNAs with polyribosomes compared to 
monoribosomes) (Fig. 5D). This result suggested that global translation of RNAs was 
unaffected by deletion of Dhps in β cells. To interrogate the translation of specific mRNAs, 
we performed RT-PCR analysis for Ccnd2 and Ccnd1 on sedimentation gradient fractions. 
Ccnd2 mRNA exhibited a shift in occupancy toward monoribosomes in DhpsΔβ islets 
compared to Cre-positive control islets, indicating its absence of engagement with 
polyribosomes (Fig. 5E). In contrast, the polyribosome engagement of Ccnd1 mRNA was 
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similar between DhpsΔβ islets and Cre-positive controls (Fig. 5F). Collectively, these results 
suggest reduced translational initiation of Ccnd2 in DhpsΔβ mouse islets.
Ornithine decarboxylase and c-Myc lie upstream of DHPS activity
DHPS utilizes the polyamine spermidine as a substrate to generate hypusine on eIF5A. We 
asked if depletion of polyamines in mice impaired β-cell proliferation similarly to loss of 
DHPS. The rate-limiting enzyme for the production of polyamines is ornithine 
decarboxylase (ODC), which is irreversibly inhibited by difluoromethylornithine (DFMO) 
(28). Male C57BL/6J mice were given DFMO (or vehicle) in their drinking water for 5 days 
prior to and concurrently with 1 week of HFD feeding. DFMO-treated mice had similar 
body weight, glucose tolerance, and β-cell mass as vehicle-treated mice (Supplemental fig. 
S2A–D). Notably, similar to DhpsΔβ mice, DFMO-treated mice exhibited reduced β-cell 
proliferation compared to controls (Supplemental fig. S2E and S2F), suggesting that ODC 
activity and polyamines are required for the β-cell proliferative response to HFD-feeding.
The transcriptional activity of the gene encoding ODC (Odc1) is regulated in part by the 
oncogenic transcription factor c-Myc (29). To test the possibility that the proliferation axis 
involving c-Myc and ODC depends upon the downstream activity of DHPS, we utilized a 
small molecule activator of c-Myc (harmine) (30) and a specific inhibitor of DHPS (Gc7) 
(31, 32) in mouse islets in vitro. Mouse islets treated with harmine exhibited an increase in 
levels of Cyclin-D2 by immunoblot, but concurrent treatment with both harmine and Gc7 
abolished this effect (Fig. 6A). Flow cytometry analysis (Fig. 6B and Supplemental fig. 
S3A) of islet cells demonstrated that a marker of cellular mitosis (phosphorylated Histone 
H3) was increased upon 72 h of harmine treatment and was reduced to baseline upon 
concurrent treatment with Gc7. To confirm that the effects seen with Gc7 are likely mediated 
through inhibition of DHPS, we next tested the effects of harmine on islets from DhpsΔβ 
mice. After harmine treatment, islets from Cre-positive control mice exhibited a significant 
increase in proliferation as measured by Ki67 staining compared to vehicle treatment; by 
contrast, treatment of DhpsΔβ mouse islets did not result in a significant increase in Ki67 
immunostaining after harmine treatment (Fig. 6C and S3B).
To interrogate the c-Myc/ODC/DHPS axis in human islets, we performed flow cytometry for 
phosphorylated Histone H3 in human islets incubated with Gc7 and/or harmine. Harmine 
treatment resulted in an increase in phosphorylated histone H3-positive cells in each of the 
four islet donors, with inhibition of this effect by concurrent Gc7 treatment (Fig. 6D and 
Supplemental fig. S4). Collectively, these data in mouse and human islets suggest that c-
Myc induction of human islet cell proliferation requires DHPS activity.
The activity of DHPS depends on PKC-ζ
A key pathway that links extracellular mitogenic signals to mRNA translation and β-cell 
proliferation is the growth factor/mTORC1 pathway (23, 33–37). Protein kinase C-ζ (PKC-
ζ) is proximal to mTORC1 (38, 39) and in mice harboring kinase-dead-PKC-ζ protein in β 
cells (β-KD-PKC-ζ), the proliferative response to obesity and insulin resistance is impaired 
(23)—a phenotype similar to DhpsΔβ mice. To determine how the mTORC1 pathway might 
be linked to the ODC/DHPS/eIF5A pathway, we examined the levels of eIF5AHyp in the 
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islets of HFD-fed β-KD-PKC-ζ mice by immunostaining. The staining intensity for 
eIF5AHyp was increased in the islets of control animals, but not in those of β-KD-PKC-ζ 
mice upon HFD feeding (Fig. 7A and 7B). Notably, staining intensity of eIF5ATotal did not 
change with diet or genotype (Fig. 7C and 7D). These findings suggest that the phenotype of 
β-KD-PKC-ζ mice may be due to the loss of eIF5AHyp formation. To confirm that DHPS is 
downstream of PKC-ζ, we next examined if activation of PKC-ζ (through its 
phosphorylation at residue Thr410) occurred in DhpsΔβ mice. Immunostaining showed that 
the phosphorylation of PKC-ζ did not differ between control and DhpsΔβ mice fed either a 
NCD or HFD (Fig. 7E and 7F). Collectively, these data suggest that DHPS lies downstream 
of PKC-ζ.
DISCUSSION
The polyamines putrescine, spermidine, and spermine participate in cellular replication, and 
their depletion by inhibition of ODC has been a focus of antiproliferative therapies for 
several cancers (40, 41). A specific role for spermidine was suggested in our prior zebrafish 
study (42) showing that inhibition of ODC, which results in reduced pancreatic cell 
proliferation, can be rescued by supplementation with spermidine. However, the mechanism 
of this rescue remained elusive. A specific role of DHPS as a downstream effector of 
spermidine has not been rigorously tested in mammals in vivo, owing in part to the 
embryonic lethality of mice harboring germline homozygous mutations in Dhps (6, 7). Our 
studies utilizing a conditional knockout mouse model of Dhps allowed the demonstration of 
a role of Dhps in β-cell proliferation.
Two concepts regarding the growth and replication of postnatal β cells have emerged. First, 
although β cells were originally considered to be post-mitotic cells in the adult mammal, it is 
now recognized that they exhibit a slow rate of replication that decreases with age (11, 12, 
17, 43). Second, the mass of β cells can be altered to compensate for insulin resistance that 
occurs during physiologic or pathologic processes, such as growth, gestation, and obesity 
and insulin resistance (44, 45). The mechanisms that underlie the compensatory gains in β-
cell mass are thought to involve both increases in cell size and number, and with respect to 
the latter, the molecular pathways triggering cell cycle entry remain incompletely 
understood. In this study, we focused on the molecular mechanisms at the onset of 
compensatory β-cell mass expansion during obesity/insulin resistance. Using an inducible β-
cell-specific knockout mouse model, we found that DHPS activity was increased in islets in 
response to HFD feeding, that DHPS was necessary for the induction of β-cell replication 
and for the maintenance of normal glucose homeostasis following HFD feeding, that DHPS 
promoted the mRNA translation of the critical cell cycle regulator Ccnd2, and that DHPS 
activity was downstream of c-Myc and PKCζ. Our studies do not entirely rule out a role for 
DHPS in the maintenance of β-cell function (in addition to mass); in many cases, mass and 
function are closely intertwined, and the defects we observed in our proteomics data (with 
alterations in pathways of protein translation and secretion) may indeed suggest some loss in 
β-cell function.
DHPS catalyzes the first and rate-limiting step of the hypusine modification of eIF5A (2). 
eIF5AHyp facilitates the elongation and termination phases of mRNA translation in yeast 
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(46). In mammals, it is unclear if eIF5AHyp functions as a general translation factor or a 
factor specific for certain mRNAs. A proteomics study of eIF5A-depleted HeLa cells has 
revealed alterations in protein folding and mRNA translation pathways, suggestive of a role 
for the factor in ER stress-related processes (47). In our study, we demonstrated that loss of 
DHPS resulted in the expected reduction in eIF5AHyp levels and acute reduction in the 
translation of a key cell cycle gene whose product, Cyclin-D2, was necessary for adaptive β-
cell replication. Notably, the loss of Dhps in β cells did not acutely affect translation 
globally, because there were no changes in either the islet PRP analysis or in the specific 
translation of another cell cycle gene (Ccnd1). Moreover, the loss of Dhps appeared to cause 
an mRNA translation initiation block, rather than a block in translation elongation or 
termination. With respect to the latter point, our findings suggest that Dhps had an effect that 
was independent of eIF5AHyp, a possibility that we think is unlikely, or that resulted from 
the accumulation of the unhypusinated form of eIF5A. Resolution of these possibilities will 
require the conditional deletion of the gene encoding eIF5A. We should note that our 
findings are distinct but mechanistically consistent with our prior observations that DHPS 
promotes the translation of key proteins involved in the apoptotic phase of ER stress in 
pancreatic islets (20).
Little is known about the regulation of eIF5AHyp formation. We linked two regulators of 
cellular proliferation, PKCζ and c-Myc, to hypusination. PKCζ is an atypical Ser/Thr 
protein kinase that lies proximal to mTOR activation (23, 39). The phenotype of β-cell 
PKCζ kinase-dead mice are similar to that of DhpsΔβ mice described here, in which defects 
in HFD-induced Cyclin-D2 activation and β-cell proliferation result in a diabetic phenotype 
(23). This observation led us to explore a possible link between the PKCζ/mTOR and 
DHPS/eIF5AHyp pathways, and we observed that eIF5A hypusination in β cells in response 
to HFD feeding required intact PKCζ activity. Conversely, activation of PKCζ (as assessed 
by phospho-PKCζ immunostaining) did not appear to be dependent upon DHPS. These 
findings therefore place PKCζ upstream of DHPS/eIF5AHyp in a pathway that links 
nutritional signals from HFD feeding to β-cell replication. c-Myc is an oncogenic 
transcription factor that can drive rodent and human β-cell replication (30, 48, 49). Because 
c-Myc is a direct transcriptional activator of the gene encoding ODC (Odc1) (29), we 
surmised that the effect of c-Myc in inducing proliferation may be mediated at least partially 
through the ODC/DHPS/eIF5AHyp axis. Our studies using the DYRK1A inhibitor harmine 
(which indirectly activates c-Myc) (30) suggest that the pro-proliferative effects of c-Myc 
are abrogated when DHPS is inhibited in mouse and human islets.
In conclusion, we demonstrated a role for DHPS in β-cell replication. Our studies involving 
the PKCζ/mTOR and c-Myc/ODC pathways implicate DHPS as a key node through which 
these pathways affect replication in the β cell (Fig. 8). Our work opens several future 
avenues of investigation, including the mechanism by which PKCζ influences eIF5A 
hypusination (through ODC compared to DHPS), the role of exogenous and endogenously-
derived spermidine as a substrate for DHPS during facultative proliferation, and the potential 
independent effect of accumulating unhypusinated eIF5A on the proliferative response. The 
resolution of these and other related issues must await the analysis of animal models with 
conditional knockout of Odc1 and Eif5a1.
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Mice containing the floxed Dhps alleles were crossed to MIP1-CreERT (21) mice to 
generate DhpsΔβ mice on the C57BL/6J background. Animals were maintained under 
protocols approved by the Indiana University School of Medicine Institutional Animal Care 
and Use Committee. The following primers were used for genotyping DhpsΔβ mice: 5’-
GTAAACTAGAGTTCTGCGATGGGTGG-3’ (forward) and 5’-
TCAATCTGGTCATAAGGGCACAGG-3’ (reverse), and were expected to generate a 319 
bp band for the wild-type allele and 396 bp for the floxed allele. Mice were crossed to 
B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J and pancreas tissue was harvested to 
visualize Tomato expression. Male mice with the desired genotype were then weaned and 
utilized for all the experiments in this study. Mice were administered 3 daily intraperitoneal 
injections of 2.5 mg of tamoxifen dissolved in peanut oil at 8 weeks of age. Mice were then 
allowed to acclimate for 1 week prior to being placed on either a NCD (16% kcal from fat; 
Research Diets; D12492) or HFD (60% kcal from fat; Research Diets; D12492). Glucose 
and insulin tolerance tests were performed as described (18). Mice harboring kinase-dead-
PKC-ζ protein in β-cells (β-KD-PKC-ζ) (23) were placed on either a NCD or HFD at 8 
weeks of age as previously described (23) and euthanized for pancreas tissue after 1 week.
Cell Isolation and Culture
Mouse islets were cultured in 11 mM glucose as previously described (50). Human islets 
were obtained from the Integrated Islet Distribution Program or from the University of 
Alberta and maintained in complete Standard Islet Medium (Prodo Labs) and supplemented 
with ciprofloxacin (Fisher Scientific). Mouse and human islets were pretreated with 100 μM 
Gc7 or vehicle (10 mM acetic acid) for 16 hours prior to concurrent treatment with 10 μM 
harmine (Sigma Aldrich) or vehicle (dimethylsulfoxide) for 48 or 72 hours prior to 
collection for western blot or flow cytometry analysis.
Immunostaining and morphometric assessment of β-cell mass and β-cell death
β-cell mass was calculated as previously detailed using at least five mice per group (51). 
Pancreata and isolated islets were stained using the following antibodies: anti-insulin (1:350, 
#A0564, Dako), anti-Ki67(1:200, #Ab66155–200, Abcam), anti-eIF5AHyp (1:200, IU-44), 
and anti-eIF5ATotal (1:200, #611977, BD Pharmingen), anti-phospho-PKC-ζ (1:100, 
SAB4503773, Sigma-Aldrich and DAPI (Thermo Fisher). Apoptosis was detected using the 
ApopTag Red In Situ Apoptosis Detection Kit (Millipore Sigma). Images were acquired 
using a Zeiss LSM800 microscope (Carl Zeiss).
Polyribosome Profiling (PRP) and RT-PCR
PRP experiments using isolated islets proceeded as described previously (52). Total RNA 
from the PRP fractions was reverse transcribed and subjected to SYBR Green-I-based 
quantitative real-time PCR. Polyribosome-to-monoribosome (P/M) ratios were quantitated 
by calculating the area under the curve corresponding to the polyribosome peaks (more than 
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two ribosomes) divided by the area under the curve for the monoribosome (80S) peak. 
Primers for Ccnd2, Ccna2, and Ccnd1 were described previously (24, 26).
Immunoblot Analysis
Whole-cell extracts from mouse islets were prepared as described previously and subjected 
to a 4–20% gradient SDS-PAGE (53). For immunoblots, antibodies were as follows: anti-
eIF5AHyp (1:3000) (54); anti-eIF5ATotal (1:3000, Clone 26, BD Biosciences); anti-ERK1/2 
(1:1,000, sc-94, Santa Cruz); anti-Cyclin-D2 (1:1,000, AB-2, Thermo Fisher Scientific); 
anti-Cyclin-D1 (1:1000, AB-1, Thermo Fisher Scientific); anti-β-tubulin (1:3000, 9F3, Cell 
Signaling); anti-DHPS (1:1000, sc-365077, Santa Cruz). Immunoblots were visualized using 
fluorescently-labeled secondary antibodies (LI-COR Biosciences) and were quantified using 
LI-COR software.
RNA-sequencing library preparation and sequencing
Purified total RNA was first evaluated for its quantity and quality using and Agilent 
Bioanalyzer 2100. All RNA samples had a RIN (RNA Integrity Number) of 8 or higher. Ten 
ng of total RNA per sample were used for library preparation. cDNA was first synthesized 
through reverse transcription with poly-dT priming, using SMART-Seq v4 Ultra Low Input 
RNA Kit for Sequencing (Takara Clontech Laboratories, Inc.), followed by cDNA shearing 
with Covaris AFA sonicator (Covaris) and size selection with AMPure beads (Beckman 
Coulter). Barcoded cDNA library was then prepared using Ion Plus Fragment Library Kit 
(Thermo Fisher Scientific). Each library was quantified and its quality assessed by Agilent 
Bioanalyzer, and multiple libraries were pooled in equal molarity. Average size of library 
insert was approximately 150 bp. Eight microliters of 100 pM pooled libraries were applied 
to Ion Sphere Particles (ISP) template preparation and amplification using Ion OneTouch 2, 
followed by ISP loading onto a PI® Chip and sequencing on Ion Proton semiconductor 
(Thermo Fisher Scientific). Each PI® Chip allows loading of about 140 million ISP 
templates, generating approximately 100 million reads up to 10–15 Gbp. A Phred quality 
score (Q score) was used to measure the quality of sequencing. More than 90% of the 
sequencing reads reached Q30 (99.9% base call accuracy).
RNA-Sequencing alignment and analysis
All sequenced libraries were mapped to the mouse genome (UCSC mm10) using STAR 
RNA-seq aligner (55). The reads distribution across the genome was assessed using bamutils 
(from ngsutils) (56). Uniquely mapped sequencing reads were assigned to mm10 refGene 
genes using featureCounts (57). Differential expression (DE) analyses were performed using 
edgeR v3.22.3 implemented in the Bioconductor package (58) to identify differentially-
expressed mRNAs between control and DhpsΔβ samples. Biological coefficients of variation 
between the samples were estimated using an empirical Bayes approach under the 
assumption that the data follows a negative binomial distribution. We filtered out low 
expression transcripts based on percentage of samples (less than 50%) and CPM cutoff of 1. 
Statistical significance was defined as p-value ≤ 0.05 and a fold change (FC) ≥ 2 of 
expression level between comparison of knockout mice and controls. The heat map and 
locus-by-locus volcano plot were performed using R package. DAVID was used for the 
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functional enrichment analysis (59), based on annotation files from GO (60), to identify 
biological pathways that were significantly enriched.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
Isolated islet samples were treated with 8 M urea in 50 mM Tris-HCl and sonicated for 
protein extraction. For each sample set, an equal amount of protein starting material was 
reduced and alkylated with tris(2-carboxyethyl)phosphine (TCEP) and chloroacetamide 
(CAM) and digested with Trypsin Gold (Promega) over night. Samples were labeled with 
0.2 mg of TMT mass tagging reagents (Proteome Sciences via Thermo Scientific). 
Approximately 100 μg of the mixed sample was fractionated using Pierce High pH 
Reversed-Phase Peptide Fractionation Kit (Thermo Scientific) and subject to LC-MS/MS 
analysis.
Column chromatography was performed in-line with a Fusion Lumos Orbitrap mass 
spectrometer with advanced precursor determination and Easy-IC using a Nanoflex Easy 
nanospray ion source. Data were acquired with the full MS acquisition performed at a 
resolution of 60,000 and MS/MS analysis performed at a resolution of 50,000. MS/MS 
fragmentation was performed by higher-energy collision dissociation (HCD) with a collision 
energy of 36.
MS/MS database search was performed with the relevant Uniprot FASTA database using 
SEQUEST HT within Proteome Discoverer 2.2 (PD 2.2, Thermo). The reporter ion 
quantitation node within PD 2.2 was used for quantitation following sample normalization 
based on the total amount of protein detected for each reporter group. For significance 
analysis, p-values were calculated using an ANOVA and a Tukey HSD post-hoc test. Locus-
by-locus volcano plot were performed using R package.
Flow cytometry
Islets were dispersed using 1 ml of Accumax (#07921, StemCell Technologies) containing 2 
U/mL of DNAse I and PluronicTM F-127 for 15 min at 37 °C. Single cells were stained with 
25 μM Newport Green PDX for 90 min at 37 °C. Cells were washed, resuspended in 1 mL 
of PBS and incubated at 37 °C for 30 min. Cells were fixed with 2 % paraformaldehyde for 
10 min and subsequently permeabilized with Transcription Factor Staining Buffer Set 
(Invitrogen). Intracellular staining was carried out in perm/wash buffer containing Ki67-PE 
(Clone 16A8, Biolegend) and Histone H3 (pS28)-Alexa Fluor 647 (Clone HTA28, BD), 
overnight 4 °C. After staining, the cells were washed, filtered and acquired on a FACS Canto 
II cytometer (BD). Data were analyzed using FlowJo software (Tree Star).
Statistical Analysis
All data are presented as mean ±SEM. For comparisons of two groups, a two-tailed unpaired 
Student’s t test was used. For comparisons of more than two groups, a one-way ANOVA was 
used followed by a Tukey post-test.
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Figure 1: β-cell-specific knockout of Dhps impairs glucose tolerance after HFD-feeding.
Control (WT, Cre+ or DhpsloxP/loxP) and DhpsΔβ (βKO) mice were fed for 4 weeks with a 
normal chow diet (NCD) or high fat diet (HFD) and metabolic parameters were assessed. 
(A) Schematic timeline showing the period of tamoxifen (TAM) injections and feeding. (B) 
Body weight at the conclusion of the feeding regimen. Data from N=5 mice per group. (C) 
Percent body fat at the conclusion of the feeding regimen. Data from N=4 mice per group. 
(D) Glucose tolerance test in NCD-fed mice. (E) Area under the curve (AUC) analysis of 
glucose tolerance tests in (D). (F) Glucose tolerance test in HFD-fed mice. (G) AUC 
analysis of glucose tolerance tests in (F). (H) Insulin tolerance test in NCD- and HFD-fed 
mice. (I) Area over the curve (AOC) of insulin tolerance test in (H). (J) Serum insulin levels 
during a glucose tolerance test. (K) Images of whole pancreatic sections from representative 
HFD-fed control and DhpsΔβ mice immunostained for insulin (brown) and counterstained 
with hematoxylin. Scale bar, 1000 μm. (L) Quantitation of pancreatic β-cell mass. Data from 
N=3–6 mice per group. (M) Representative images of pancreata stained for TUNEL (red), 
insulin (green) and nuclei (DAPI, blue). Scale bar, 50 μm. (N) Quantification of TUNEL 
immunostaining (N=3 mice per group). Data presented as mean ± SEM; *p-value < 0.05 for 
the comparisons shown by one-way ANOVA.
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Figure 2: RNA-sequencing and proteomics of control and β-cell-specific Dhps knockout islets.
Control (Cre+ and DhpsloxP/loxP) and DhpsΔβ (βKO) mice were fed a NCD or HFD for 4 
weeks. Data from N=3 mice per group. (A) Principal component analysis displaying the 
variance of RNA-sequencing data obtained from control and βKO islets. (B) Volcano plot of 
differentially-expressed mRNAs in comparison between control and DhpsΔβ islets. (C) Gene 
Ontology Enrichment Analysis for mRNA sequencing data. (D) Heatmap of differentially-
expressed genes involved in cellular proliferation. (E) Volcano plot of differentially-
expressed proteins in comparison between control and DhpsΔβ mice. Data from N=3–6 mice 
per group. (F) Gene Ontology Enrichment Analysis from proteomics data.
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Figure 3: Hypusination of eIF5A is increased after 1 week of high fat diet feeding.
Control Cre+ and DhpsΔβ (βKO) mice were fed for 1 week with NCD or HFD and 
eIF5AHyp and eIF5ATotal levels were assessed by immunostaining of pancreas sections. (A) 
Representative images of pancreata stained for eIF5AHyp (magenta), insulin (green), and 
nuclei (DAPI, blue). Scale bar, 50 μm. (B) Quantification of eIF5AHyp immunostaining in 
(A) from N=3 animals per group. (C) Representative images of pancreata stained for 
eIF5ATotal (magenta), insulin (green), and nuclei (DAPI, blue). Scale bar, 50 μm. (D) 
Quantification of eIF5ATotal immunostaining in (C). Data from N=3 animals per group. Data 
presented as mean +/− SEM; *p-value < 0.05 for the comparisons shown by one-way 
ANOVA.
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Figure 4: β-cell-specific Dhps knockout mice exhibit normal glucose tolerance after 1 week of 
high fat diet feeding.
Control (Cre+, WT, and DhpsloxP/loxP) and DhpsΔβ (βKO) mice were fed for 1 week with 
NCD or HFD and metabolic parameters were assessed. (A) Glucose tolerance test in NCD-
fed mice. (B) Area under the curve (AUC) analysis for glucose tolerance tests from NCD-
fed mice in (A). (C) Serum insulin levels in NCD-fed mice in (A). Data from N=3 Cre+ and 
DhpsloxP/loxP mice, N=5 DhpsΔβ mice. (D) β-cell mass in NCD-fed mice in (A). N=3 mice 
per group. (E) Glucose tolerance test in HFD-fed mice. (F) AUC analysis for glucose 
tolerance tests in (E). (G) Serum insulin levels in HFD-fed mice in (E). Data from N=3 Cre+ 
and DhpsloxP/loxP mice, N=4 DhpsΔβ mice. (H) β-cell mass in HFD-fed mice in (E). Data 
from N=3 Cre+ and DhpsloxP/loxP mice, N=5 DhpsΔβ mice. (I) Representative images of 
pancreata from the indicated mice stained for Ki67 (magenta, arrow), insulin (green), and 
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nuclei (DAPI, blue). Scale bar, 50 μm. (J) Quantification of Ki67 immunostaining in (I), 
data from N=3–5 animals per group. Data presented as mean ± SEM; *p-value < 0.05 by 
one-way ANOVA.
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Figure 5: Decreased mRNA translation of Cyclin-D2 in DhpsΔβ mice.
(A) Schematic showing experimental design. Control (Cre+) and DhpsΔβ (βKO) mice were 
fed a HFD for 1 week and islets were isolated and subjected to RT-PCR and polyribosome 
profiling (PRP) analysis. (B) Quantitative RT-PCR from islets for the genes indicated. Data 
from N=5–6 animals per group. (C) Representative immunoblot analysis from islets for 
Cyclin-D2, Cyclin-D1, and Erk½ (left) and quantification of immunoblots (right). Data from 
N=3–5 animals per group. (D) PRP of isolated islets (left) and quantification of 
polyribosome:monoribosome ratio (right). Data from N=3 mice per group. (E) Quantitative 
RT-PCR of Cycd2 in polyribosomal fractions. Data from N=3–4 mice per group. (F) 
Quantitative RT-PCR of Cycd1 in polyribosomal fractions. Data from N=3–4 mice per 
group. Data presented as mean ± SEM; *p-value < 0.05 by T test.
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Figure 6: DHPS inhibition attenuates harmine-induced β cell proliferation in mouse and human 
islets.,
(A) Islets were isolated from male 8–9 week old CD1 mice, then treated in vitro with vehicle 
(V), harmine (H), and Gc7 (G). Representative immunoblot (top) and quantification of 
protein levels (bottom) for Cyclin-D2. Data are from N=6 mice per group. (B) Islets were 
isolated from male 8–9 week old CD1 mice, then treated in vitro with vehicle (V), harmine 
(H), and Gc7, followed by flow cytometry analysis of dispersed islet cells immunostained 
for phospho-histone H3. Data are from N=4–6 mice per group. (C). Islets were isolated from 
control (Cre+) and DhpsΔβ (βKO) mice, then treated in vitro with vehicle (V) or harmine 
(H), then percent of β cells that immunostained for Ki67 was calculated. Data are from N=3 
animals per group. (D) Human islets from 4 donors were treated in vitro with vehicle, 
harmine, and/or Gc7 (G), dispersed, immunostained for phospho-histone H3, then subjected 
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to flow cytometry analysis. Graphs show a single technical replicate for each donor. Data in 
A, B, and C are presented as mean ± SEM; *p-value < 0.05 by one-way ANOVA.
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Figure 7: Hypusine generation requires PKCζ.
Wildtype (WT) and kinase-dead-PKCζ (KD) mice were fed a NCD or HFD for 1 week. (A) 
Representative images of pancreata stained for eIF5AHyp (magenta), insulin (green), and 
nuclei (DAPI, blue). (B) Quantification of eIF5AHyp levels from (A). Data are from N=3 
mice per group. (C) Representative images of pancreata stained for eIF5ATotal (magenta), 
insulin (green), and nuclei (DAPI, blue). (D) Quantification of eIF5ATotal levels from (B). 
Data are from N=3 mice per group. (E) Representative images of NCD- and HFD-fed 
control and DhpsΔβ (βKO) mouse pancreata immunostained for phospho-PKCζ (red), 
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insulin (green), and nuclei (DAPI, blue). Scale bar, 50 μm. (F) Quantification of phospho-
PKCζ immunostaining in insulin positive cells shown in (E). Data are from N=3 mice per 
group. Data presented as mean ± SEM; *p-value < 0.05 for the comparisons shown by one-
way ANOVA.
Levasseur et al. Page 25













Figure 8. Proposed pathway linking PKCζ, c-Myc, and polyamines to adaptive proliferation in β 
cells.
The schematic diagram shows the proposed positioning of the PI3K- PKCζ-mTOR pathway 
(left arm of the diagram) and the polyamine-eIF5A pathway (right arm of the diagram) 
relative to the adaptive translational and proliferative responses. The hierarchy of the factors 
depicted in red (PKCζ, c-Myc, ODC, and DHPS) have been shown in this study or others to 
serve as key nodes through which proliferative responses are mediated – deletion or 
inhibition of these factors severely restricts the ability of the β cell to produce Cyclin-D2 and 
undergo replication. This study demonstrated that DHPS is downstream of PKCζ, c-Myc, 
and ODC functions. This study does not explicitly rule out the possibility that PKCζ might 
directly or indirectly regulate the function of DHPS (shown as a dashed line with a question 
mark).
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